Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis
Authors
Keywords
CD56, Acute myeloid leukemia, Prognosis, Meta-analysis
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 141, Issue 10, Pages 1859-1870
Publisher
Springer Nature
Online
2015-04-30
DOI
10.1007/s00432-015-1977-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis
- (2014) Jordi Juncà et al. ANNALS OF HEMATOLOGY
- Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
- (2014) J. M. Middeke et al. BLOOD
- Direct involvement of CD56 in cytokine-induced killer–mediated lysis of CD56+ hematopoietic target cells
- (2014) Rut Valgardsdottir et al. EXPERIMENTAL HEMATOLOGY
- Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia
- (2014) Friederike Pastore et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
- (2013) Takaaki Ono et al. CANCER SCIENCE
- Molecular Cytogenetics and Multiplex Reverse-Transcriptase Polymerase Chain Reaction for Risk Stratification in Acute Myeloid Leukemia
- (2013) Kristina Orendi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia
- (2013) Tilmann Bochtler et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
- (2013) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)
- (2013) Noriyoshi Iriyama et al. LEUKEMIA RESEARCH
- Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients
- (2013) Massimo Breccia et al. LEUKEMIA RESEARCH
- Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype
- (2012) Harry Dang et al. HUMAN PATHOLOGY
- RUNX1Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures
- (2012) Jason H. Mendler et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia
- (2011) Irena Djunic et al. MEDICAL ONCOLOGY
- Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
- (2010) P. Montesinos et al. BLOOD
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Acute Myeloid Leukemia
- (2010) Carolyn J. Hildreth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation
- (2010) Allan Jiang et al. LEUKEMIA RESEARCH
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started